<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ribavirin/PMC7404195/results/search/drugs/results.xml">
  <result pre="being approved in over a decade. While cholinesterase inhibitors and" exact="memantine" post="are FDA-approved drugs for AD, and do address some"/>
  <result pre="impairments. The study found that the co-administration of acyclovir with" exact="dexamethasone" post="attenuated impairments in spatial cognition. Furthermore, this combination reduced"/>
  <result pre="study found these effects to only occur when acyclovir and" exact="dexamethasone" post="were administered together [114]. 4.1.2. Penciclovir Penciclovir is another"/>
  <result pre="HSV-1 displayed a reduction of virus and Aβ accumulation when" exact="penciclovir" post="was administered. This was paralleled with a reduction in"/>
  <result pre="in AD. 4.2. Antimicrobial Drugs 4.2.1. Doxycycline Doxycycline is a" exact="tetracycline" post="antibiotic that has been studied for its therapeutic efficacy"/>
  <result pre="its therapeutic efficacy in AD models. Contrary to other tetracyclines," exact="doxycycline" post="has been determined to be safe and is able"/>
  <result pre="effect directly in the CNS. In vivo models, in which" exact="doxycycline" post="was administered to mice, observed its accumulation in amyloid"/>
  <result pre="and formation of Aβ oligomers, it was observed that although" exact="doxycycline" post="administration in transgenic mice did not cause a shift"/>
  <result pre="a reduction in microglia activation has also been associated with" exact="doxycycline" post="administration [132]. A drosophila model, which administered doxycycline to"/>
  <result pre="associated with doxycycline administration [132]. A drosophila model, which administered" exact="doxycycline" post="to Aβ1–42-expressing flies, observed that the treated group’s locomotor"/>
  <result pre="slower than the control group. The same study also observed" exact="doxycycline" post="administration to be associated with reduced Aβ fibrilization, suggesting"/>
  <result pre="the production of smaller amyloid structures [133]. Another study associated" exact="doxycycline" post="with the destabilization of Aβ fibrils [134]. Clinical trials,"/>
  <result pre="trials, however, were not as successful. One study, which administered" exact="doxycycline" post="and rifampicin, observed improvements in cognitive function, as assessed"/>
  <result pre="reduced microglial activation [141]. Studies by Tomiyama et al. found" exact="rifampicin" post="to protect neurons from cytotoxicity by scavenging free radicals"/>
  <result pre="scavenging free radicals [142,143]. In relation to the antimicrobial hypothesis," exact="rifampicin" post="has been previously studied for use in bacterial cerebral"/>
  <result pre="previously studied for use in bacterial cerebral infections [144]. As" exact="rifampicin" post="is able to cross the BBB [144], it can"/>
  <result pre="clearance [145]. A study by Umeda et al., in which" exact="rifampicin" post="was administered to APPOSK mice, found the treatment to"/>
  <result pre="reduce microglial activation [146]. Clinical studies exploring the impact of" exact="rifampicin" post="on cognitive function have also been investigated, as mentioned"/>
  <result pre="sections. Even with its many benefits, the oral intake of" exact="rifampicin" post="has also been associated with liver injury in humans."/>
  <result pre="with liver injury in humans. To circumvent this limitation, administering" exact="rifampicin" post="intranasally or subcutaneously has been suggested [147]. These routes"/>
  <result pre="intranasally or subcutaneously has been suggested [147]. These routes of" exact="rifampicin" post="administration have been shown to be more effective in"/>
  <result pre="in the brain, more so than other antibiotics, such as" exact="moxifloxacin" post="[153,154]. In addition, COR271 was found to provide some"/>
  <result pre="effects that could take away from its benefits. For example," exact="cefepime" post="is an antibiotic that has shown to be able"/>
  <result pre="virus type 1J. Alzheimer’s Dis.20081425926910.3233/JAD-2008-1430118599953 114.HuiZ.ZhijunY.YushanY.LipingC.YiyingZ.DifanZ.ChunglitC.T.WeiC.The combination of acyclovir and" exact="dexamethasone" post="protects against Alzheimer’s disease-related cognitive impairments in micePsychopharmacology202010.1007/s00213-020-05503-132221697 115.PrasadK.M.EackS.M.KeshavanM.S.YolkenR.H.IyengarS.NimgaonkarV.L.Antiherpes"/>
  <result pre="Alzheimer’s disease mouse modelsNeurobiol. Aging20187012813910.1016/j.neurobiolaging.2018.06.00230007162 133.CostaR.SperettaE.CrowtherD.C.CardosoI.Testing the therapeutic potential of" exact="doxycycline" post="in a Drosophila melanogaster model of Alzheimer diseaseJ. Biol."/>
  <result pre="Abeta42Int. J. Mol. Sci.201920464110.3390/ijms2018464131546787 135.LoebM.B.MolloyD.W.SmiejaM.StandishT.GoldsmithC.H.MahonyJ.SmithS.BorrieM.DecoteauE.DavidsonW.et al.A randomized, controlled trial of" exact="doxycycline" post="and rifampin for patients with Alzheimer’s diseaseJ. Am. Geriatr."/>
  <result pre="Geriatr. Soc.20045238138710.1111/j.1532-5415.2004.52109.x14962152 136.MolloyD.W.StandishT.I.ZhouQ.GuyattG.A multicenter, blinded, randomized, factorial controlled trial of" exact="doxycycline" post="and rifampin for treatment of Alzheimer’s disease: The DARAD"/>
  <result pre="antibiotic with brain protective functionBrain Res. Bull.2014107374210.1016/j.brainresbull.2014.05.00724905548 140.YulugB.HanogluL.OzansoyM.IsıkD.KilicU.KilicE.SchabitzW.R.Therapeutic role of" exact="rifampicin" post="in Alzheimer’s diseasePsychiatry Clin. Neurosci.20187215215910.1111/pcn.1263729315976 141.BiW.ZhuL.JingX.LiangY.TaoE.Rifampicin and Parkinson’s diseaseNeurol."/>
  <result pre="function as a hydroxyl radical scavengerJ. Biol. Chem.19962716839684410.1074/jbc.271.12.68398636108 144.MindermannT.LandoltH.ZimmerliW.RajacicZ.GratzlO.Penetration of" exact="rifampicin" post="into the brain tissue and cerebral extracellular space of"/>
  <result pre="space of ratsJ. Antimicrob. Chemother.19933173173710.1093/jac/31.5.7318335500 145.QosaH.AbuznaitA.H.HillR.A.KaddoumiA.Enhanced brain amyloid-β clearance by" exact="rifampicin" post="and caffeine as a possible protective mechanism against Alzheimer’s"/>
  <result pre="a candidate preventive medicine against amyloid-β and tau oligomersBrain20161391568158610.1093/brain/aww04227020329 147.UmedaT.TanakaA.SakaiA.YamamotoA.SakaneT.TomiyamaT.Intranasal" exact="rifampicin" post="for Alzheimer’s disease preventionAlzheimer’s Dement.2018430431310.1016/j.trci.2018.06.01230094330 148.LiN.CollyerC.A.Gingipains from Porphyromonas gingivalis—Complex"/>
 </snippets>
</snippetsTree>
